Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Hanne

Hanne Caspersen, Amersfoort NL

Patent application numberDescriptionPublished
20090143914SYSTEM FOR OPERATING MODES FOR AN ELECTRIC TOOTHBRUSH - Various operational mode arrangements of an electric toothbrush (06-04-2009

Hanne Christensen, København F DK

Patent application numberDescriptionPublished
20100184687Purification of Glucagon-Like Peptides - Method for purifying a glucagon-like peptide by reversed phase high performance liquid chromatography.07-22-2010

Hanne Dela, Copenhagen DK

Patent application numberDescriptionPublished
20100212091FAMILY 44 XYLOGLUCANASES - The present invention relates to xyloglucanases belonging to family 44 of glycosyl hydrolases and having a relative xyloglucanase activity of at least 30% between pH 5 and pH 8 are derived from the genus 08-26-2010

Patent applications by Hanne Dela, Copenhagen DK

Hanne Dela, Copenhagen DE

Patent application numberDescriptionPublished
20120079665FAMILY 44 XYLOGLUCANASES - The present invention relates to xyloglucanases belonging to family 44 of glycosyl hydrolases and having a relative xyloglucanase activity of at least 30% between pH 5 and pH 8 are derived from the genus 04-05-2012

Hanne Gahery-Segard, Paris FR

Patent application numberDescriptionPublished
20080213818CELLULAR IMMUNITY TEST WITH PEPTIDES ATTACHED TO A SOLID SUPPORT - The invention concerns a method for detecting cellular immunity (with respect to an antigen), using a solid support whereon is fixed an assortment of peptides constituting T cell epitopes of the antigen to be tested, kits for implementing said method.09-04-2008

Hanne Jørgensen, Trondheim NO

Patent application numberDescriptionPublished
20110117606NRPS-PKS Gene Cluster and its Manipulation and Utility - The present invention provides a nucleic acid molecule comprising: (a) a nucleotide sequence as shown in SEQ ID No. 1; or (b) a nucleotide sequence which is the complement of SEQ ID No. 1; or (c) a nucleotide sequence which is degenerate with SEQ ID No. 1; or (d) a nucleotide sequence having at least 85% sequence identity (preferably at least 87%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% sequence identity) with SEQ ID No. 1; or (e) a part of any one of (a) to (d), wherein said nucleic acid molecule encodes or is a complementary to a nucleic acid molecule encoding one or more polypeptides, or comprises or is complementary to a nucleic acid molecule comprising one or more genetic elements, having functional activity in the synthesis of a polyketide-based or macrolactam molecule. Particularly the invention contemplates the modification of the nucleic acid of the invention, encoding the biosynthetic machinery for the synthesis of the polyketide macrolactam BE-14106, including expressing in a microorganism the modified nucleic acid molecule. In certain aspects the modification includes introducing, mutating, deleting, replacing or inactivating a sequence encoding one or more activities or proteins encoded by said nucleic acid molecule. Other aspects of the invention include a microorganism containing the modified and unmodified nucleic acid and recovering the polyketide-based or macrolactam molecule from said mircoorganism.05-19-2011

Hanne Meritt, Emeryville, CA US

Patent application numberDescriptionPublished
20100249126PYRIMIDINE DERIVATIVES USED AS PI-3-KINASE INHIBITORS - Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.09-30-2010

Hanne Nedergaard, Kobenhavn DK

Patent application numberDescriptionPublished
20090075895Stabilised Solid Composition of Modified Factor VII - The invention concerns a composition comprising; i) Modified Factor VII; ii) an agent suitable for keeping the pH of said composition in the range of 4 to 7 when said composition is dissolved in water; and iii) a moisture content of at the most 3%.03-19-2009

Hanne Ravneberg, Bergen NO

Patent application numberDescriptionPublished
20110262905KIT FOR THE OPTIMISATION OF PROTEIN SYNTHESIS/SECRETION - The invention relates to a kit to be used for the identification of a secretion cassette, which in eukaryotic cells gives rise to a higher level of synthesis/secretion of a protein of interest, the coding sequence of which being flanked by the first and the second set of genetic elements, respectively, compared to the other secretion cassettes present in the kit containing the coding sequence at the corresponding position, as well as to a method wherein the kit is used and the use of said kit, whereby the best secretion cassette will be obtained.10-27-2011

Hanne Skomedal, Klokkarstua NO

Patent application numberDescriptionPublished
20110111386CERVICAL CELL COLLECTION METHOD - The present invention relates to sample collection and preservation. More specifically, the invention provides methods for the collection and preservation of at least one nucleic acid molecule in a test sample comprising one or more cells or tissues obtained from the cervix of a subject.05-12-2011

Hanne Skomedal, Borgen NO

Patent application numberDescriptionPublished
20110275698"TEST AND TREAT" STRATEGY FOR TREATING TRANSFORMING HPV INFECTION - The invention is concerned with a “test and treat” method of screening and directly treating female subjects having transforming or abnormal human papillomavirus (HPV) infection.11-10-2011
20120016593METHOD AND APPARATUS FOR WORLDWIDE SREENING FOR HUMAN PAPILLOMA VIRUS - The invention relates to in vitro methods of screening female human subjects for the presence of human papillo mavirus, for example as a marker of cervical epithelial precancer. In particular, the invention provides methods and apparatus which can be used to filter a patient data set of measurements related to multiple HPV types according to the geographical location of the patient under test, so that only those measurements of HPV types which are pre-determined to be relevant for the geographical region in which the patient under test is located are selected for output/display.01-19-2012

Hanne Wigum, Trondheim NO

Patent application numberDescriptionPublished
20100099780FISCHER-TROPSCH CATALYSTS - A method of producing an alumina-supported catalyst for use in a Fischer-Tropsch synthesis reaction, which comprises: calcining an initial γ-alumina support material at a temperature of at least 550° C. to produce a modified alumina support material; impregnating the modified alumina support material with a source cobalt; calcining the impregnated support material at a temperature of 700° C. to 1200° C., and activating the catalyst.04-22-2010